A process for the production of coated textiles comprises the steps of: providing a textile substrate having a first side and a second side opposing the first side; contacting at least a part of the first side of the textile substrate with a spreadable polyurethane mechanical foam; applying a reduced pressure to at least a part of the second side of the textile substrate opposing the first side which has been contacted with the polyurethane mechanical foam; and solidifying the polyurethane mechanical foam with which the textile substrate has been contacted. The invention further relates to a coated textile obtainable by such a process, in particular a synthetic leather.

A process for the production of coated textiles comprises the steps of: providing a textile substrate having a first side and a second side opposing the first side; contacting at least a part of the first side of the textile substrate with a spreadable polyurethane mechanical foam; applying a reduced pressure to at least a part of the second side of the textile substrate opposing the first side which has been contacted with the polyurethane mechanical foam; and solidifying the polyurethane mechanical foam with which the textile substrate has been contacted. The invention further relates to a coated textile obtainable by such a process, in particular a synthetic leather.

The present invention relates to trisodium diethylenetriamine pentaacetic acid (DTPA) prodrugs, such as, for example, DTPA di-ethyl esters. The invention further relates to compositions comprising DTPA prodrugs and methods of using the same.

The present invention relates to trisodium diethylenetriamine pentaacetic acid (DTPA) prodrugs, such as, for example, DTPA di-ethyl esters. The invention further relates to compositions comprising DTPA prodrugs and methods of using the same.

The present invention relates to trisodium diethylenetriamine pentaacetic acid (DTPA) prodrugs, such as, for example, DTPA di-ethyl esters. The invention further relates to compositions comprising DTPA prodrugs and methods of using the same.

The present invention discloses a method for resolving cyclohexylphenyl glycolic acid and the preparation of optically active phenylcyclohexyl glycolate esters. More particularly, the invention provides a process for preparation of optically active R-oxybutynin hydrochloride with high enantiomeric purity of greater than 99%.

The present invention discloses a method for resolving cyclohexylphenyl glycolic acid and the preparation of optically active phenylcyclohexyl glycolate esters. More particularly, the invention provides a process for preparation of optically active R-oxybutynin hydrochloride with high enantiomeric purity of greater than 99%.